US Stock MarketDetailed Quotes

BBLG Bone Biologics

Watchlist
  • 1.2500
  • +0.0200+1.63%
Close Nov 22 16:00 ET
3.08MMarket Cap-356P/E (TTM)

Bone Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
77.61%-572.16K
75.34%-895.87K
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
Net income from continuing operations
50.98%-941K
55.70%-783.73K
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
Operating gains losses
106.21%9.97K
99.15%-10.79K
-106.63%-37.31K
69.35%-892.69K
---24.76K
---160.65K
---1.27M
--562.92K
---2.91M
----
Other non cash items
----
----
----
----
----
----
----
---1
47.66%731.71K
----
Change In working capital
168.89%340.93K
80.52%-118.79K
-125.84%-452.81K
178.94%132.92K
29.15%-514.51K
-162.53%-494.89K
-773.99%-609.9K
640.60%1.75M
47.46%-168.37K
-1,023.30%-726.21K
-Change in prepaid assets
295.72%362K
-1,159.62%-249.46K
-72.54%99.25K
125.68%245.73K
77.01%-187.44K
46.08%91.48K
-126.49%-19.8K
229.51%361.49K
---956.93K
-1,763.01%-815.19K
-Change in payables and accrued expense
93.70%-41.82K
-87.12%85.69K
-1,426.51%-552.07K
13,655.69%670.87K
190.40%628.01K
-191.11%-664.02K
4,131.15%665.26K
192.49%41.62K
101.33%4.88K
-2,444.23%-694.69K
-Change in other working capital
-73.29%20.74K
----
----
-200.00%-783.68K
---955.08K
--77.65K
---1.26M
--1.35M
1,641.50%783.68K
----
Cash from discontinued investing activities
Operating cash flow
77.61%-572.16K
75.34%-895.87K
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
1.81M
-99.99%299
1.5M
13.87%5.04M
-86.64%592K
0
4.45M
0
-43.95%4.43M
-35.41%4.43M
Net common stock issuance
---226
-100.00%-137
--1.5M
13.87%5.04M
-86.64%592K
--0
--4.45M
--0
-35.41%4.43M
--4.43M
Proceeds from stock option exercised by employees
--1.81M
----
----
----
----
--0
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
--1.81M
-99.99%299
--1.5M
13.87%5.04M
-86.64%592K
--0
--4.45M
--0
-43.95%4.43M
-35.41%4.43M
Net cash flow
Beginning cash position
-66.72%2.33M
-47.84%3.23M
-59.85%3.03M
12.93%7.54M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
--6.68M
149,847.93%5.06M
Current changes in cash
148.31%1.23M
-209.28%-895.57K
114.89%201.07K
-622.83%-4.51M
-157.52%-1.43M
-546.44%-2.56M
327.60%819.49K
-56.83%-1.35M
-87.07%862.95K
-62.84%2.48M
End cash Position
-19.90%3.57M
-66.72%2.33M
-47.84%3.23M
-59.85%3.03M
-59.85%3.03M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
12.93%7.54M
Free cash flow
77.61%-572.16K
75.34%-895.87K
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 77.61%-572.16K75.34%-895.87K3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M
Net income from continuing operations 50.98%-941K55.70%-783.73K76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K
Operating gains losses 106.21%9.97K99.15%-10.79K-106.63%-37.31K69.35%-892.69K---24.76K---160.65K---1.27M--562.92K---2.91M----
Other non cash items -------------------------------147.66%731.71K----
Change In working capital 168.89%340.93K80.52%-118.79K-125.84%-452.81K178.94%132.92K29.15%-514.51K-162.53%-494.89K-773.99%-609.9K640.60%1.75M47.46%-168.37K-1,023.30%-726.21K
-Change in prepaid assets 295.72%362K-1,159.62%-249.46K-72.54%99.25K125.68%245.73K77.01%-187.44K46.08%91.48K-126.49%-19.8K229.51%361.49K---956.93K-1,763.01%-815.19K
-Change in payables and accrued expense 93.70%-41.82K-87.12%85.69K-1,426.51%-552.07K13,655.69%670.87K190.40%628.01K-191.11%-664.02K4,131.15%665.26K192.49%41.62K101.33%4.88K-2,444.23%-694.69K
-Change in other working capital -73.29%20.74K---------200.00%-783.68K---955.08K--77.65K---1.26M--1.35M1,641.50%783.68K----
Cash from discontinued investing activities
Operating cash flow 77.61%-572.16K75.34%-895.87K3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 1.81M-99.99%2991.5M13.87%5.04M-86.64%592K04.45M0-43.95%4.43M-35.41%4.43M
Net common stock issuance ---226-100.00%-137--1.5M13.87%5.04M-86.64%592K--0--4.45M--0-35.41%4.43M--4.43M
Proceeds from stock option exercised by employees --1.81M------------------0----------------
Cash from discontinued financing activities
Financing cash flow --1.81M-99.99%299--1.5M13.87%5.04M-86.64%592K--0--4.45M--0-43.95%4.43M-35.41%4.43M
Net cash flow
Beginning cash position -66.72%2.33M-47.84%3.23M-59.85%3.03M12.93%7.54M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M--6.68M149,847.93%5.06M
Current changes in cash 148.31%1.23M-209.28%-895.57K114.89%201.07K-622.83%-4.51M-157.52%-1.43M-546.44%-2.56M327.60%819.49K-56.83%-1.35M-87.07%862.95K-62.84%2.48M
End cash Position -19.90%3.57M-66.72%2.33M-47.84%3.23M-59.85%3.03M-59.85%3.03M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M12.93%7.54M
Free cash flow 77.61%-572.16K75.34%-895.87K3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data